Mark Pickin

Publications

Salisbury C, Goodall S, Montgomery AA, Pickin DM, Edwards S, Sampson F, Simons L, Lattimer V. Does Advanced Access improve access to primary health care? Questionnaire survey of patients. Br J Gen Pract. 2007 Aug;57(541):615-21.

Salisbury C, Montgomery AA, Simons L, Sampson F, Edwards S, Baxter H, Goodall S, Smith H, Lattimer V, Pickin DM. Impact of Advanced Access on access, workload, and continuity: controlled before-and-after and simulated-patient study. Br J Gen Pract. 2007 Aug;57(541):608-14.

Cooper C, Pickin M, Chater T, O´Hagan T, Abrams K, Cooper N, Boggild M, Palace J, Ebers G and Nicoll J. MS Risk Sharing Scheme Monitoring Study Final report (Confidential) March 2006

Goodall S, Montgomery A, Banks J, Salisbury C, Sampson F, Pickin M. Implementation of Advanced Access in general practice: postal survey of practices.Br J Gen Pract. 2006 Dec;56(533):918-23.

Dixon S, Sampson FC, O'Cathain A, Pickin M. Advanced access: more than just GP waiting times? Fam Pract. 2006 Apr;23(2):233-9. Epub 2005 Dec 19.

Copping JR, Payne N, Pickin DM. Evaluation of an innovative approach to the Director of Public Health's annual report.Public Health. 2005 May;119(5):448-54.

Cooper C, Palace J, Pickin, M, Boggild M, Nicholl J. (2004). The Multiple Sclerosis Monitoring Study: Progress to date. Journal of Neurology Neurosurgery and Psychiatry 2004; 75:1213-1228. ABN Spring Meeting 2004 Abstracts.

Cooper C L, Pickin DM, Cross E, Boggild M, Nicholl JP, 2004 (2004). Research Governance – the death-knell of multi-centre studies? Journal of Epidemiology and Community Health. September 2004 58 Suppl ll A7.

Sampson F, Munro J, Pickin M, Nicholl J. Why are patients removed from their doctors´ lists? A comparison of patients´ and doctors´ accounts of removal. Family Practice 2004: 21(5); 515-518

Pickin DM, O´Cathain A, Fall M, Morgan AB, Howe A, Nicholl JP. The impact of a general practice co-operative on accident and emergency services, patient satisfaction and GP satisfaction. Fam Pract 2004, 21:180-182

Pickin M, O´Cathain A, Sampson FC, Dixon S. Evaluation of Advanced Access in the National Primary Care Collaborative. Br J Gen Pract 2004, 54:334-340

Munro J F, Sampson F, Pickin D M. Rapid response: What has not been said is also important. At: http://bmj.com/cgi/eletters/326/7402/1316#33589. BMJ 2003

Pickin M, O´Cathain A, Sampson F, Dixon S, Nicholl J. Evaluation of the National Primary Care Collaborative Advanced Access Programme. Final report to the Department of Health. December 2002.

Munro J, Sampson F, Pickin M, Nicholl J. Patient de-registration from GP lists and professional and patient perspectives: Final report to the Department of Health. February 2002.

Pickin M, Sampson F, Munro J, Nicholl J. General practitioners´ experience and views of removing patients from their lists: postal survey in England and Wales. BMJ 2001;322:1158-9.

Pickin DM, McCabe CJ, Ramsay LE, Payne N. Cost effectiveness of statins. Heart 2000;83:714 (Letter)

Morgan A, Shackley P, Pickin M, Brazier J. Quantifying patient preferences for out-of-hours primary care. J Health Serv Res Policy 2000;5:214-218

Pickin DM, McCabe CJ, Ramsay LE, Payne N, Haq IU, Yeo WW, Jackson PR. Cost-effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart 1999;82:325-332

Pickin DM, McCabe C. Lipid Lowering in the United Kingdom National Health Service: Effectiveness and cost - the economic view. Proceedings of the Royal College of Physicians of Edinburgh 1999;29(2):31-40

Ebrahim S, Davey Smith G, McCabe C, Payne N, Pickin M, Sheldon TA, et al. What role for statins? A review and economic model. Health Technol Assess 1999;3(19)Ebrahim S, Davey-Smith G, McCabe C, Payne JN, Pickin DM, Sheldon TA et al. Cholesterol and Coronary Heart Disease: Screening and Treatment. Quality in Health Care 1998;7(4):232-239

Ebrahim S, Lampe F, Wannamthee G, Davey-Smith G, McCabe C, Payne JN, Pickin DM, Sheldon TA et al. Cholesterol and Coronary Heart Disease: Screening and Treatment. Effective Health Care Bulletin, NHS Centre for Reviews and Dissemination 1998

Sampson F, Ward S, Pickin DM, Payne JN. The Development of a Decision Support Tool for Evaluation of Alternative Policies on HMG Co-A Reductase Inhibitor (Statin) Prescribing. Final Report to Trent Regional Health Authority. May 1998.

Nicholl JP, Turner J, Pickin DM. A review of the evidence for the provision of emergency services. Sheffield: Medical Care Research Unit, 1997

O´Cathain A, Munro JF, Nicholl JP, Pickin DM, Fall M. Evaluation of the North Derbyshire Emergency Medical Services Pilot Project. Sheffield: Medical Care Research Unit, 1997

Haq I, Ramsay L, Pickin DM, Yeo WW, Jackson PR, Payne JN. Lipid lowering strategies for the prevention of coronary heart disease: authors´ reply. Clinical Science 1997;92:431-2 (Letter)

Wallis EJ, Ramsay LE, Yeo WW, Jackson PR, Pickin M, Haq IU. Use of statins – Evidence on effectiveness is stronger for statins than for other treatments. BMJ 1997;315:1618-9 (Letter)

Pickin DM. Review of "Evidence-based and cost-effective medicine for the uninitiated". Journal of Public Health Medicine 1997;19(4):485-486
Haq I, Ramsay L, Pickin DM, et al. Lipid-lowering for prevention of coronary heart disease: what policy now? Clinical Science 1996 91:399-413.

Ramsay L, Haq I, Jackson PR, Yeo WW, Pickin DM, Payne N. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. The Lancet 1996;348:387-388.

(Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. The Sheffield table for primary prevention of coronary heart disease: corrected. The Lancet 1996;348:1251-1252.)

Pickin DM, Payne JN, Haq I, et al. HMG Co-A reductase inhibitor treatment in the prevention of coronary heart disease: guidance notes for purchasers. Sheffield:Trent Institute for Health Services Research, 1996.

Nicholl JP, Parry GJ, Coleman P, Pickin DM. The provision of emergency ambulance services in South Yorkshire. Sheffield: Medical Care Research Unit, 1995.

Pickin DM, Nicholl JP. Number who benefit per unit of treatment may be a more appropriate measure. BMJ 1995;310:1270 (Letter)

Lovering AM, White LO, Lewis DA, MacGowan AP, Routh KR, Pickin DM, Reeves DS. Pharmacokinetics of FCE 22101 in man following different modes of administration. Journal of Antimicrobial Chemotherapy 1989;23(SC):179-195.

MacGowan AP, Bailey RA, Egner W, Pickin DM, Reeves DS. An open study of the efficacy and safety of single dose fosfomycin trometamol treatment of hospitalised patients with UTI's. Infection 1990;18(S2):107-108.

Refereed Conference Contributions

Cooper C, Palace J, Pickin M, Boggild M, Nicholl J. (2004). The Multiple Sclerosis Monitoring Study: Progress to date. Association of British Neurologists Spring Meeting, London, UK, April 2004.

Cooper C L, Pickin DM, Cross E, Boggild M, Nicholl JP, 2004 (2004). Research Governance – the death-knell of multi-centre studies? Society for Social Medicine Annual Scientific Meeting. Birmingham, UK, September 2004.

Sampson FC, Munro JF, Pickin DM, Nicholl J. What leads to GPs removing patients from their lists? Results of a survey of removed patients and their GPS. Strategic Issues in Healthcare Management Fifth International Conference, St Andrews, Scotland April 2002.

Sampson FC, Munro JF, Pickin DM, Nicholl JP. Patient removal from the doctor´s list: GP and patient perspectives. Joint conference of the International Epidemiological Association & the Society for Social Medicine Annual Scientific Meeting, Oxford, UK, 2001.

Pickin DM, Sampson F, Munro J, Nicholl J. Unwanted customers? Doctors reasons for removing patients from their lists. Annual Scientific Meeting of The European Public Health Association. Paris, France, 2000
Pickin DM, Sampson F, Munro J, Nicholl J. Why do GPs remove patients from their lists? A survey of GP views and attitudes. Trent Public Health Conference. Nottingham, UK, 2000

Pickin DM, Cornell J, Booth A, Morris F, Wardrope J, Nicholl J. How much of medical care is evidence-based? The case of accident and emergency medicine. Society for Social Medicine 43rd Annual Scientific Meeting. Sheffield, UK, 1999. (Plenary presentation)
Fall M, Pickin DM, Morgan AB, Brazier JE, Howe A, Nicholl JP. Out of hours cooperatives: the general practitioner´s view. Society for Social Medicine 43nd Annual Scientific Meeting. Sheffield, UK, 1999.

Pickin DM, Cornell J, Booth A, Morris F, Wardrope J, Nicholl JP. How much of medical care is evidence-based? The case of accident and emergency medicine. 15th International Meeting of the International Society of Technology Assessment in Health Care. Edinburgh, UK. 20-23 June 1999.

Pickin DM, Payne JN, Sampson F, McCabe CJ, Ebrahim S, Davey-Smith G, Sheldon TA. Cost-effectiveness of interventions to reduce mortality from coronary heart disease. Society for Social Medicine 42nd Annual Scientific Meeting. Cardiff, UK, 1998.

Pickin DM, McCabe CJ, Ramsay L, Payne JN, Haq IU, Yeo WW, Jackson PR. Cost-effectiveness of statin therapy. 14th International Meeting of the International Society of Technology Assessment in Health Care. Ottawa, Canada, 1998.

Booth A, Pickin DM, Cornell J. Creating a specialty knowedge base: an effective approach to evidence-based practice? Advances in Clinical Knowledge Management conference. London, UK, 1998.

O´Cathain A, Munro JF, Nicholl JP, Pickin DM, Fall M. Barriers to using GP commissioning to control demand for emergency medical services. Strategic Issues in Health Care Management: 3rd international conference. Fife, UK, 1998.

Pickin DM, Payne JN, Haq I, McCabe CJ, Ward S, Jackson PR, Yeo WW, Ramsay L. The use of statins in the prevention of coronary heart disease. 13th International Meeting of the International Society of Technology Assessment in Health Care. Barcelona, Spain, 1997.

Ramsay LE, Haq IU, Pickin DM, Yeo WW, Jackson PR, Payne JN. How cost effective is primary, secondary and tertiary prevention with lipid-lowering agents? British Cardiac Society annual scientific meeting, Glasgow, UK, 1996.